Bruch-Gerharz Daniela, Schnorr Oliver, Suschek Christoph, Beck Karl-Friedrich, Pfeilschifter Josef, Ruzicka Thomas, Kolb-Bachofen Victoria
Research Group Immunobiology, University of Duesseldorf, Germany.
Am J Pathol. 2003 Jan;162(1):203-11. doi: 10.1016/S0002-9440(10)63811-4.
Abnormal proliferation of keratinocytes in the skin appears crucial to the pathogenesis of psoriasis, but the underlying mechanisms remain unknown. Nitric oxide (NO), released from keratinocytes at high concentrations, is considered a key inhibitor of cellular proliferation and inducer of differentiation in vitro. Although high-output NO synthesis is suggested by the expression of inducible NO synthase (iNOS) mRNA and protein in psoriasis lesions, the pronounced hyperproliferation of psoriatic keratinocytes may indicate that iNOS activity is too low to effectively deliver anti-proliferative NO concentrations. Here we show that arginase 1 (ARG1), which substantially participates in the regulation of iNOS activity by competing for the common substrate L-arginine, is highly overexpressed in the hyperproliferative psoriatic epidermis and is co-expressed with iNOS. Expression of L-arginine transporter molecules is found to be normal. Treatment of primary cultured keratinocytes with Th1-cytokines, as present in a psoriatic environment, leads to de novo expression of iNOS but concomitantly a significant down-regulation of ARG1. Persistent ARG1 overexpression in psoriasis lesions, therefore, may represent a disease-associated deviation from normal expression patterns. Furthermore, the culturing of activated keratinocytes in the presence of an ARG inhibitor results in a twofold increase in nitrite accumulation providing evidence for an L-arginine substrate competition in human keratinocytes. High-output NO synthesis is indeed associated with a significant decrease in cellular proliferation as shown by down-regulation of Ki67 expression in cultured keratinocytes but also in short-term organ cultures of normal human skin. In summary, our data demonstrate for the first time a link between a human inflammatory skin disease, limited iNOS activity, and ARG1 overexpression. This link may have substantial implications for the pathophysiology of psoriasis and the development of new treatment strategies.
皮肤中角质形成细胞的异常增殖似乎对银屑病的发病机制至关重要,但其潜在机制仍不清楚。角质形成细胞高浓度释放的一氧化氮(NO)在体外被认为是细胞增殖的关键抑制剂和分化诱导剂。尽管银屑病皮损中诱导型一氧化氮合酶(iNOS)mRNA和蛋白的表达提示有高产量的NO合成,但银屑病角质形成细胞明显的过度增殖可能表明iNOS活性过低,无法有效产生抗增殖浓度的NO。我们在此表明,精氨酸酶1(ARG1)通过竞争共同底物L-精氨酸大量参与iNOS活性的调节,在过度增殖的银屑病表皮中高度过表达,并与iNOS共表达。发现L-精氨酸转运分子的表达正常。用银屑病环境中存在的Th1细胞因子处理原代培养的角质形成细胞,导致iNOS的从头表达,但同时ARG1显著下调。因此,银屑病皮损中ARG1的持续过表达可能代表了与疾病相关的正常表达模式偏差。此外,在ARG抑制剂存在的情况下培养活化的角质形成细胞,导致亚硝酸盐积累增加两倍,为人角质形成细胞中的L-精氨酸底物竞争提供了证据。如培养的角质形成细胞以及正常人皮肤的短期器官培养中Ki67表达下调所示,高产量的NO合成确实与细胞增殖的显著降低相关。总之,我们的数据首次证明了一种人类炎症性皮肤病、有限的iNOS活性和ARG1过表达之间的联系。这种联系可能对银屑病的病理生理学和新治疗策略的开发具有重要意义。